Clinical Trial Update: A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis [Phase 2]

View source ↗

Summary

Phase 2 study results for pimavanserin in Alzheimer's disease psychosis have been posted from a completed trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Alzheimer Disease Psychosis

Drugs mentioned

• Pimavanserin (pimavanserin)

Snippet

Sponsor: ACADIA Pharmaceuticals Inc. | Conditions: Alzheimer's Disease Psychosis | Phase 2 | Status: COMPLETED | Results posted: 2017-10-25